Innovation Directory – Wales

Public Health Wales is the national public health agency. Public Health Wales is responsible for protecting and improving health and wellbeing and reducing health inequalities.

Pureability is a product development consultancy who work with healthcare manufacturers and suppliers. The company provides advice on product development, including research, prototyping, manufacturing, accreditation, marketing and logistics.

Purolite (owned by Ecolab, a provider of water, hygiene and infection prevention products and services) develops and manufactures resin-based separation, purification and extraction technology. This technology has several applications within healthcare and life sciences, including for biotherapeutic manufacturing, diagnostics and biocatalysis. Purolite's site in Llantrisant specialises in producing products for life science applications.

QuidelOrtho offer diagnostic products such as laboratory supplies, kits, reagents and instruments to clinical and research laboratories. This include immunohaematology assays and point-of-care tests for a range of diseases

R&D Surgical is a medical device and equipment manufacturer and distributor. The company offers a range of products in the cardiac, thoracic, dental and general surgery fields

Reacta Healthcare manufacture challenge meals for use in clinical trials (meals used to diagnose and monitor food allergy) by developing and producing allergens.

Recliners is a company based in Pentre, Mid Glamorgan which designs, develops, manufactures and supplies electrical and manual furniture, including healthcare seating products.

RED MedTech are a product development and compliance consultancy who specialise in medical devices. Services offered include design and regulatory advice and assistance with technical filings.

RedKnight are a grant-funding consultancy who offer services such as bid-writing and grant claim management. The company works across a range of sectors, including in healthcare and life sciences.

ReNeuron have developed an exosome technology platform that offers a delivery mechanism for a variety of potential payloads that could include siRNA, mRNA, proteins, small molecules and genes to a defined cell type in a selected tissue. The company are now seeking partnerships with companies developing promising drug candidates that may benefit from using this platform